Shuttle Pharmaceuticals Holdings (SHPH) Capital Expenditures (2026)

Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Capital Expenditures came in at $36000.0 in Q1 2026.

Shuttle Pharmaceuticals Holdings (SHPH) Capital Expenditures (2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Capital Expenditures history runs 1 years deep, the most recent figure standing at $36000.0 for Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 168.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 110.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.95 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 99.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 39.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.40 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 51.00 Mn
10 Shuttle Pharmaceuticals Holdings 120,186.04 120,186.04 - 36,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 36,000.00
Mar 31, 2026 36,000.00